Table 3.
Energy and nutrients intake of subjects with polycystic ovarian syndrome
| Variables | Intervention (n = 99) |
Placebo (n = 95) |
P2 | P3 | ||||
|---|---|---|---|---|---|---|---|---|
| Before | After | P1 | Before | After | P1 | |||
| Energy (kcal/day) | 3424.24 ± 769.51* | 2216.61 ± 590.47 | < 0.001 | 3101.48 ± 748.6 | 2189.48 ± 633.14 | < 0.001 | 0.5 | 0.801 |
| Protein (g/day) | 121.03 ± 37.11 | 84.81 ± 24.01 | < 0.001 | 106.68 ± 32.09 | 84.22 ± 25.21 | < 0.001 | 0.158 | 0.91 |
| Carbohydrate (g/day) | 500.17 ± 140.71 | 348.57 ± 102.75 | < 0.001 | 460.17 ± 138.14 | 342.79 ± 113.71 | < 0.001 | 0.704 | 0.591 |
| Fat (g/day) | 106.82 ± 33.75 | 56.13 ± 18.54 | < 0.001 | 93.91 ± 28.19 | 55.89 ± 20.92 | < 0.001 | 0.193 | 0.639 |
| Vitamin D (IU/day) | 2.77 ± 5.37 | 2.32 ± 2.38 | 0.402 | 1.93 ± 3.81 | 2.11 ± 2.34 | 0.098 | 0.043 | 0.66 |
*All presented values are means ± SD
P1: P values denote significance of within-group changes
P2: P values denote significance of between-group difference in the baseline
P3: P values denote significance of between-group difference after intervention
*Significant difference within group throughout the study (P < 0.05, paired samples t test or Wilcoxon)
*Significant difference between groups throughout the study (P < 0.05, independent samples t test or U Mann–Whitney